CVE-2015-1012

CVE-2015-1012 is a high-severity vulnerability in Pfizer Lifecare Pca Infusion System Firmware with a CVSS 3.x base score of 7.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-200.

Key facts

Description

Wireless keys are stored in plain text on version 5 of the Hospira LifeCare PCA Infusion System. According to Hospira, version 3 of the LifeCare PCA Infusion System is not indicated for wireless use, is not shipped with wireless capabilities, and should not be modified to be used in a wireless capacity in a clinical setting. Hospira has developed a new version of the PCS Infusion System, version 7.0 that addresses the identified vulnerabilities. Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.

Frequently asked questions

What is CVE-2015-1012?
Wireless keys are stored in plain text on version 5 of the Hospira LifeCare PCA Infusion System. According to Hospira, version 3 of the LifeCare PCA Infusion System is not indicated for wireless use, is not shipped with wireless capabilities, and should not be modified to be used in a wireless capacity in a clinical setting. Hospira has developed a new version of the PCS Infusion System, version 7.0 that addresses the identified vulnerabilities. Version 7.0 has Port 20/FTP and Port 23/TELNET closed by default to prevent unauthorized access.
How severe is CVE-2015-1012?
CVE-2015-1012 has a CVSS 3.x base score of 7.5, rated high severity. It is exploitable over network with low attack complexity, requires no privileges and no user interaction. Impact on confidentiality is high, integrity none, and availability none.
Is CVE-2015-1012 being actively exploited?
It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (51st percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2015-1012?
CVE-2015-1012 affects Pfizer Lifecare Pca Infusion System Firmware. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2015-1012?
Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround. Given its high severity, prioritise patching exposed systems.
When was CVE-2015-1012 published?
CVE-2015-1012 was published on 2019-03-25 and last updated on 2026-06-17.

References

Affected products (1)

Other CWE-200 (Exposure of Sensitive Information to an Unauthorized Actor) vulnerabilities

Browse all CWE-200 (Exposure of Sensitive Information to an Unauthorized Actor) vulnerabilities →